Dr. Bijan Najafi, PhD
Claim this profileStudies Chronic Obstructive Pulmonary Disease
Studies Pulmonary Disease
1 reported clinical trial
1 drug studied
More about Bijan Najafi, PhD
Clinical Trial Related7 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Bijan Najafi, PhD has experience with
- Exercise
Breakdown of trials Bijan Najafi, PhD has run
Chronic Obstructive Pulmonary Disease
Pulmonary Disease
Cardiovascular Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Bijan Najafi, PhD specialize in?
Bijan Najafi, PhD focuses on Chronic Obstructive Pulmonary Disease and Pulmonary Disease. In particular, much of their work with Chronic Obstructive Pulmonary Disease has involved treating patients, or patients who are undergoing treatment.
Is Bijan Najafi, PhD currently recruiting for clinical trials?
No, Bijan Najafi, PhD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Bijan Najafi, PhD has studied deeply?
Yes, Bijan Najafi, PhD has studied treatments such as Exercise.
What is the best way to schedule an appointment with Bijan Najafi, PhD?
Apply for one of the trials that Bijan Najafi, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.